Merck’s Pivotal Phase 3 C-EDGE Program Evaluating Grazoprevir/Elbasvir Shows High Sustained Virologic Responses Across ...

Media coverage

• Title	Merck’s Pivotal Phase 3 C-EDGE Program Evaluating Grazoprevir/Elbasvir Shows High Sustained Virologic Responses Across ...
  Media name/outlet	World News Report
  Country	United States
  Date	4/24/15
  Persons	Eric J Lawitz

• Title	Merck’s Pivotal Phase 3 C-EDGE Program Evaluating Grazoprevir/Elbasvir Shows High Sustained Virologic Responses Across ...
  Media name/outlet	EIN News
  Country	United States
  Date	4/24/15
  Persons	Eric J Lawitz